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Validity of oral mucosal transudate specimens for HIV testing using enzyme-
linked immunosorbent assay in children in Chimanimani district, Zimbabwe
Wilson Mashange, Stella May Gwini, Stanford T Mahati, Stephen S Buzuzi, Chenjerai K Mutambanengwe, Shungu Munyati,  
Brian Chandiwana, Simbarashe Rusakaniko, Exnevia Gomo
Objective. To assess the validity of oral mucosal transudate (OMT) 
specimens for HIV testing in children using enzyme-linked 
immunosorbent assay (ELISA).
Methods. A cross-sectional descriptive study was conducted as 
part of a community-based behavioural and HIV sero-status survey 
of adults and children in the Chimanimani district of Zimbabwe. 
Dried blood spot (DBS) and OMT samples were collected from 
children aged between 2 and 14 years, inclusive. Both samples were 
tested for HIV using the Vironostika Uniform II plus O kits. The 
main study outcomes were the sensitivity and specificity of OMT 
samples, with DBS as the gold-standard specimen.
Results. Paired DBS and OMT specimens were available from 
1 274 (94.4%) of the 1 350 children enrolled. Using the DBS, HIV 
prevalence was 3.2%. Overall sensitivity of OMT was 48.8% (95% 
confidence interval (CI) 33.3 - 64.5), and specificity was 98.5% 
(95% CI 97.7 - 99.1). 
Conclusion. The overall sensitivity of OMT specimens for HIV 
testing in children using ELISA was low. Stratifying the analysis 
by sector showed that OMT samples are good specimens for HIV 
testing. It is important to note that factors such as the low HIV 
prevalence in our study population, quality of the OMT, diet and 
oral hygiene could have influenced the results. 
S Afr Med J 2011; 101: 49-52.
Nearly 70% of all human immunodeficiency virus (HIV) infections 
are in sub-Saharan Africa, an area that is home to only 10% of the 
world’s population.1 In Zimbabwe the prevalence of HIV peaked 
at 33% in 20012 and had declined to 15.3% by 2007.1 Nevertheless, 
between 1.2 and 1.4 million people, including children, were living 
with HIV and AIDS in Zimbabwe in 2007.1 
Most HIV prevalence data for children are inferred indirectly, 
because it is difficult to collect blood specimens from them. 
Alternative specimens with simpler and less invasive collection 
techniques are therefore needed to generate accurate data and 
improve access to antiretroviral therapy (ART) by children. While 
blood remains the most reliable specimen for HIV testing, oral 
mucosal transudate (OMT) specimens produce reliable results when 
collected for HIV testing using the Orasure device and tested with the 
enzyme-linked immunosorbent assay (ELISA).3 OMT is a salivary 
component from the capillaries of the gingival gum margin and has 
a high concentration of immunoglobulin G (IgG). Sensitivity and 
specificity of OMT specimens in HIV testing are high in adults,4-5 but 
it is inappropriate to infer these results to their use in children. Their 
validity in HIV diagnosis in infants has been assessed in South Africa, 
with sensitivities of 82% and 95%.6-7 In contrast, a study in Uganda8 
found low sensitivity for OMT specimens from children. 
Collection of OMT specimens is non-invasive, thereby eliminating 
adverse effects associated with venepuncture (through both occupational 
exposure9 and accidental piercing by discarded needles10), is more 
acceptable to participants,11 and in some cases decreases costs12 since it 
can be used easily outside the clinic. In addition, collection and storage 
are simple. Factors influencing the accuracy and clinical utility of OMT 
as a specimen include the HIV prevalence in the study population, 
clinical conditions, and the type of population being tested.13 Other 
factors include quality control and quality assurance procedures during 
collection, and storage and testing of the samples. ART and low levels 
of seroconversion can result in false-negative results, and some medical 
conditions, bacterial contamination and elevated bilirubin can interfere 
with the test results.14
The value of OMT as a diagnostic specimen in HIV infection 
has not been assessed in Zimbabwe, and few studies have tested the 
validity of the specimen for HIV testing among children. Regardless 
of the HIV test method applied, OMT is likely to be advantageous 
since it is more acceptable to children than collection of blood. 
OMT samples were therefore collected from children to assess their 
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sensitivity and specificity in HIV diagnosis using the Vironostika 
Uniform II commercial HIV-1/2 plus O kit. 
Methods
This study was part of a 2004 cross-sectional behavioural risk and HIV 
sero-status survey conducted in Chimanimani district, Zimbabwe. 
Children between the ages of 2 and 14 years, inclusive, were enrolled. 
A structured questionnaire was administered by research assistants 
to parents/guardians of the 2 - 11-year-old children and directly to 
children aged 12 - 14 years. 
Specimen collection and testing
DBS specimens were collected on Whatman No.3 filter paper, 
following instructions from Whatman International.15 The blood 
spots were air-dried for at least 15 minutes away from direct sunlight 
and placed in appropriately labelled paper envelopes. OMT specimens 
were collected using the OraSure HIV-1 Oral Specimen Collection 
Device, following the manufacturer’s instructions (Organon Technika, 
Netherlands).16 Before transportation to the laboratory, the DBS 
specimens were stored in a cool, dry place and the OMT specimens 
at room temperature. OMT specimens have been shown to be stable 
at temparatures below 370C for at least 21 days.17 In the laboratory, all 
specimens were stored at -200C.
All OMT specimens were tested within 6 weeks of collection. 
The Vironostika Uniform II plus O (BioMérieux, Netherlands) 
commercial ELISA kit, which is licensed for use with the Orasure 
collection device,18 was used to test for the presence of HIV 
antibodies. A similar Vironostika Uniform II kit routinely used 
with blood products was used to assay the DBS following the 
manufacturer’s instructions.
Quality control 
Quality and quantity of specimens were checked in the field and in the 
laboratory. All specimens were transferred to the laboratory within 14 days 
of collection. Quality checks included verification of labelling, quantity of 
each specimen, and checking for contamination of specimens.
 Sufficiency of the DBS was determined by the size of the spot 
and whether the filter paper was soaked. A white filter-paper punch 
within 24 hours signified complete elution. Positive and negative 
control specimens provided by the manufacturer of the testing kits 
were used to assess intra-run and inter-run variation. In-house 
controls were also used, and Levy-Jennings charts were constructed 
(results not shown). Any analytical run (ELISA plate) that violated the 
standards was rejected, regardless of results obtained for other control 
materials. The controls were also sent to an external laboratory as 
part of a national programme of the Zimbabwe National Quality 
Assuarance Programme.
Ethical considerations
The study was approved by the Medical Research Council of 
Zimbabwe and by local and traditional leaders in Chimanimani. 
Participation in the study and collection of both the DBS and OMT 
specimens was voluntary. Written informed consent was sought from 
the children’s parents/guardians and assent from the children. HIV 
testing was anonymous, although bar codes were used in order to link 
the questionnaire, DBS and OMT specimens. Parents/guardians who 
wanted to know the results of the tests were referred to the nearest 
district voluntary counselling and testing centre.
Data analysis
Data were entered using EPI Info version 6 and analysed using 
both SPSS 8.0 and STATA 7.0. Descriptive statistics were presented 
as medians (with lower and upper quartiles) for interval data and 
frequencies for categorical data. The chi-square test for association 
was used to check for associations between categorical variables. 
Evaluation of sensitivity, specificity, positive predictive value (PPV), 
negative predictive value (NPV) and test efficiency (TE) was done 
to determine the validity of the OMT specimen in HIV testing with 
DBS as the gold standard. TE refers to the overall ability of a test to 
correctly identify all positives and negatives, i.e. total effectiveness 
of an assay.
A detailed description of the methodology is provided in a report 
by Gomo et al.19
Results
Characteristics of the study population
A total of 1 819 children were approached; 1 350 (74.2%) agreed 
to participate and provided DBS specimens. Of the 1 350 DBS 
specimens collected, 1 290 (95.6%) were considered sufficient for 
HIV testing. OMT specimens were collected from 1 335 (73.4%) of 
the 1 819 children who were approached. Of these, 1 334 (99.9%) 
were considered sufficient for HIV testing. A total of 1 274 children 
provided specimens that were adequate as both DBS and OMT 
samples, and the remainder of the analysis presented refers only to 
these children (Fig. 1).
The median age of the 1 274 children who had paired DBS and 
OMT specimens was 10 years (lower quartile 5, upper quartile 13), 
and 46.6% were aged 12 - 14 years. There was an equal distribution 
of males and females (Table I), and 49.4% of children were from the 
communal areas and 24.6% from the resettlement areas.
HIV prevalence
Using the DBS as the gold standard test, HIV prevalence was 3.2% 
overall. Prevalence was highest in the 6 - 8-year age group, but the 
difference according to age group was not statistically significant 
(p=0.168). The prevalence was twice as high in females as in males 
(4.2 v. 2.2%; p=0.040). 
Fig. 1. Flow chart showing recruited participants.
Fig. 1. Flow chart showing recruited participants. 
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Sensitivity and specificity of OMT
According to OMT specimens, 43 children tested positive for HIV. Of 
the 43, only 21 (48.8%) also tested positive on DBS specimens. Of the 
1 231 children who tested HIV negative on OMT specimens, 18 were 
positive according to DBS results (Table II).
Overall sensitivity of OMT was therefore low (48.8%), while 
specificity was high (98.5%) (Table III). The test efficiency was 96.8% 
(95% confidence interval (CI) 95.8 - 97.8). At a prevalence of 3.2%, 
the positive predictive value (PPV) was 52.4% and the negative 
predictive value 98.3%. 
Sensitivity was low (less than 70%) in most of the sectors, but it 
was higher than the overall for all the sectors except the urban sector 
(take note of the large CIs). Two wards (one rural, one urban) had 
much higher discordant results than other wards. Further analysis 
excluding the two wards gave a sensitivity of 70.4% (95% CI 49.8 - 
86.5), and specificity increased to 99.7% (95% CI 99.2 - 99.9) and 
PPV to 89.0%. 
Discussion 
Serum, plasma or dried blood spots are the most commonly used 
specimens for HIV diagnosis in Zimbabwe and the rest of the world. 
These specimens are difficult to collect from children, especially 
infants. OMT collection is less invasive than blood collection, may 
have fewer culturally linked misconceptions, and may therefore be 
more acceptable than DBS, serum and plasma.20 It could therefore 
increase the participation rate among children.
Sensitivity, specificity and other diagnostic parameters of OMT 
were assessed using DBS as the gold standard specimen. Overall 
sensitivity of OMT specimens was very low at 48.8%, but specificity 
was high (98.5%). While low sensitivity for children has also been 
observed in another study,8 sensitivities above 80% among infants 
were found in two studies.6,7 The prevalence of HIV infection in the 
latter was much higher (about 11%) than that observed in this study 
(3.2%), so the low HIV prevalence could have influenced the senstivity 
of the OMT specimens.13 The low sensitivity of OMT specimens in 
HIV testing in children in this study could have resulted from the 
children moving during specimen collection, so that saliva instead of 
OMT was collected, as suggested by Emmons et al.10 Although IgG 
was not measured in this study, low levels of IgG in OMT could also 
have resulted in the low sensitivity.20,21 The positive predictive value 
of 52.4% indicates that under the conditions of this study, OMT 
specimens are not suitable for HIV screening in children. 
Variations in the sensitivity of OMT specimens between this and 
other studies could also be due to differences in study settings. In 
most of the studies that have shown high sensitivities, specimens were 
from blood banks and public health, medical and STI/HIV clinics, 
whereas we collected our specimens in the households, outside 
clinical settings. Other factors contributing to the discrepancy could 
include dietary factors and oral hygiene. It is worth noting that the 
test efficiency, which refers to the total effectiveness of an assay, was 
high (96.8%).
Conclusion 
The overall sensitivity of OMT specimens for HIV testing in children 
using ELISA was low. Stratifying the analysis by sector showed that 
OMT may be a good specimen for HIV testing. The reasons for the 
sectoral and age differences could be technical or biological, and 
require further investigation. It is important to note that factors such 
as low HIV prevalence in our study population, quality of the OMT, 
diet and oral hygiene may have influenced the results.
We sincerely thank the participants and the local authority leaders, 
without whom this study could not have been successful. We also thank 
the W K Kellogg Foundation for funding the study, and the Human 
Sciences Research Council, South Africa, the Biomedical Research and 
Training Institute and the National Institute of Health Research of the 
Ministry of Health and Child Welfare, Zimbabwe, for the resources they 
provided. Special mention goes to Mrs J Mutsvangwa, Mrs J Magwenzi, 
Table I.  Distribution of children enrolled according to sex, 
age group and sector 
Males Females
N (N (%)) (N (%))
Total 1 274 638 636
Age group (yrs)
2 - 5 323 (25.4) 172 (53.3) 151 (46.7)
6 - 8 188 (14.8) 90 (47.9) 98 (52.1)
9 - 11 169 (13.3) 73 (43.2) 96 (56.8)
12 - 14 594 (46.6) 303 (51.0) 291 (49.0)
Sector
Communal 629 (49.4) 312 (49.6) 317 (50.4)
Resettlement 313 (24.6) 155 (50.5) 158 (50.5)
LSC 152 (11.9) 72 (47.4) 80 (52.6)
SSC 63 (4.9) 36 (57.1) 27 (42.9)
Urban 117 (9.2) 63 (53.9) 54 (46.1)
LSC = large-scale commercial; SSC = small-scale commercial. 
Table II. Concordance and discordance of the test results according to sector (N (%))
                                                                 Sector
Overall
(N=1 274)
Communal Resettlement LSC SSC Urban
(N=629) (N=313) (N=152) (N=63) (N=117)
DBS neg. + OMT neg. 602 (95.7) 305 (97.4) 145 (95.4) 62 (98.4) 98 (83.8) 1 213 (95.2)
DBS pos. + OMT pos. 9 (1.4) 5 (1.6) 4 (2.6) 1 (1.6) 2 (1.7) 21 (1.7)
DBS pos. + OMT neg. 9 (1.4) 0 (0.0) 1 (0.7) 0 (0.0) 8 (6.8) 18 (1.4)
DBS neg. + OMT pos. 9 (1.4) 3 (1.0) 2 (1.3) 0 (0.0) 9 (7.7) 22 (1.7)
LSC = large-scale commercial; SSC = small-scale commercial; neg. = negative; pos. = positive.
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